News

Clinic Secret is a telehealth provider specializing in prescription therapies for weight loss. It connects patients with U.S.-licensed doctors who review medical information and prescribe medications, ...
Medicare drug plans generally cover the oral form of semaglutide for FDA-approved uses. Learn more about coverage and costs.
Medicare drug plans usually cover the pill form of semaglutide for type 2 diabetes. Learn more about coverage and costs.
People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.
In February, the US Food and Drug Administration removed semaglutide injection products from its shortage list and gave compounders 60-90 days to stop making copies. Hims is up 74% this year.
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets Provided by ACCESS Newswire Jun 23, 2025, 12:05:00 AM ...
A new daily weight loss pill has shown promising results in initial studies. Researchers say amycretin, which can be offered by injection or tablet, helped patients lose a significant amount of weight ...
Cigna now offers employers $200 Wegovy, Zepbound copay option The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
(RTTNews) - Novo Nordisk announced a series of initiatives to further support patient access to FDA-approved Wegovy, or semaglutide, injection 2.4 mg as federal ban on mass compounding of ...